CVS vs ELV — Key Metrics
| Metric | CVS (CVS HEALTH CORP) | ELV (ELEVANCE HEALTH INC) |
|---|---|---|
| Price | 81.35 | 400.84 |
| Market Cap | 104.09 Billion | 86.6 Billion |
| P/E (TTM) | 9.38 | 16.97 |
| P/B (Quarterly) | 1.271 | 2.099 |
| P/S (TTM) | 0.25 | 0.43 |
| Net Profit Margin (TTM) | 2.6 | 2.5 |
| Gross Margin (TTM) | 14.2 | 15.5 |
| ROE (TTM) | 14.1 | 11.6 |
| Revenue Growth YoY (TTM) | n/a | n/a |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
Outperform
Outperform
Recommendation Summary
Both stocks are projected to outperform the market over the next year. If you have to make a choice, Upfront Recommendation: ELV.
Financial Metrics
| CVS | Metrics | ELV |
|---|---|---|
| $81.35 | Price | $400.84 |
| — | Market Capitalization | — |
| 9.38 | Price to Earnings Ratio | 16.97 |
| 0.25 | Price to Sales | 0.43 |
| 6.69 | Price to FCF Ratio | 13.3 |
| 1.74 | Price to Gross Profit | 2.77 |
| 1.31 | Price to Current Assets | 1.26 |
CVS vs ELV at a glance
CVS Health Corp (CVS) and Elevance Health INC (ELV) are both Healthcare Plans companies in the Healthcare sector. CVS is the larger, at $104.1 billion in market value against $86.6 billion for ELV, about 1.2 times the size.
On trailing-twelve-month figures, CVS trades at 9.4 times trailing earnings and ELV at 17.0; net profit margins are 2.6% and 2.5%.
The Upfront Investment model currently rates both Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.